November 23, 2021 -- The U.S. National Institute of Allergy and Infectious Diseases (NIAID), an agency of the National Institutes of Health, awarded a seven-year contract valued at up to $545 million to ATCC to aid NIAID's research efforts in infectious and allergic diseases.
Under the indefinite delivery/indefinite quality contract, ATCC will support NIAID's Division of Clinical Research, Division of Intramural Research, and the Vaccine Research Center by providing rapid response capabilities to infectious diseases, such as COVID-19, as well as services, like assay development and vaccine production.
ATCC is a biological materials and information resource and standards organization, as well as a developer and supplier of authenticated cell lines and microorganisms.
Copyright © 2021 scienceboard.net
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Conferences
Connect
